Sign Out
Epoetin beta (Recormon) is contraindicated in patients with: Known hypersensitivity to the active substance or any of the excipients.
Poorly controlled hypertension.
In the indication "increasing the yield of autologous blood", Epoetin beta (Recormon) must not be used in patients who, in the month preceding treatment, have suffered a myocardial infarction or stroke, patients with unstable angina pectoris, or patients who are at increased risk of deep venous thrombosis such as those with a history of venous thromboembolic disease.
Continue with Google